Literature DB >> 9558022

Small intestinal transit time and intraluminal pH in ileocecal resected patients with Crohn's disease.

J Fallingborg1, P Pedersen, B A Jacobsen.   

Abstract

The pH and transit times of the gut are important for the delivery of active drug from several tablets used in the treatment of Crohn's disease (CD). Many patients with CD undergo an ileocecal resection, which might influence small intestinal pH and transit time. The effect of ileocecal resection on these variables has not previously been studied. Intraluminal pH and transit time were measured in nine ileocecal-resected CD patients and 13 healthy volunteers using pH-sensitive radiocapsules. Small intestinal transit time (SITT) was significantly shorter in ileocecal-resected patients (5.2 hr, controls 8.0 hr). The pH levels of the small intestine were identical in patients and controls, whereas cecal pH was 0.9 pH units higher in resected CD patients. The time spent with pH higher than 5.5, 6.0, 6.5, and 7.0 was significantly shorter in patients than in controls. There was no correlation between the SITT and the length of resected ileum or between the SITT and the time elapsed since the resection. We conclude that ileocecal resection decreases the SITT and the time with pH higher than 5.5-7.0. The study indicates that this reduction of the SITT is mainly due to the resection of the ileocecal valve and is, to a certain extent, independent of the length of resected ileum. An ileocecal resection might therefore affect the delivery of active drug from tablets with pH-dependent delivery.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9558022     DOI: 10.1023/a:1018893409596

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  14 in total

1.  pH-profile and regional transit times of the normal gut measured by a radiotelemetry device.

Authors:  J Fallingborg; L A Christensen; M Ingeman-Nielsen; B A Jacobsen; K Abildgaard; H H Rasmussen
Journal:  Aliment Pharmacol Ther       Date:  1989-12       Impact factor: 8.171

2.  Measurement of gastrointestinal pH profiles in normal ambulant human subjects.

Authors:  D F Evans; G Pye; R Bramley; A G Clark; T J Dyson; J D Hardcastle
Journal:  Gut       Date:  1988-08       Impact factor: 23.059

3.  The competence and bacteriologic effect of the telescoped intestinal valve after small bowel resection.

Authors:  A M Kholoussy; Y Yang; K Bonacquisti; T Witkowski; K Takenaka; T Matsumoto
Journal:  Am Surg       Date:  1986-10       Impact factor: 0.688

4.  Intestinal cancer risk and mortality in patients with Crohn's disease.

Authors:  P Munkholm; E Langholz; M Davidsen; V Binder
Journal:  Gastroenterology       Date:  1993-12       Impact factor: 22.682

5.  An accurate, long-term, pH-sensitive radio pill for ingestion and implantation.

Authors:  R H Colson; B W Watson; P D Fairclough; J A Walker-Smith; C A Campbell; D Bellamy; S M Hinsull
Journal:  Biotelem Patient Monit       Date:  1981

6.  Dissolution profiles of mesalazine formulations in vitro.

Authors:  L M Stolk; R Rietbroek; E H Wiltink; J J Tukker
Journal:  Pharm Weekbl Sci       Date:  1990-10-19

7.  Improved localizing method of radiopill in measurement of entire gastrointestinal pH profiles: colonic luminal pH in normal subjects and patients with Crohn's disease.

Authors:  Y Sasaki; R Hada; H Nakajima; S Fukuda; A Munakata
Journal:  Am J Gastroenterol       Date:  1997-01       Impact factor: 10.864

8.  Assessment of orocoecal transit time by means of a hydrogen (H2) breath test as compared with a radiologic control method.

Authors:  U Armbrecht; J Jensen; S Eden; R Stockbrügger
Journal:  Scand J Gastroenterol       Date:  1986-08       Impact factor: 2.423

9.  A new slow-release form of 5-aminosalicylic acid for the oral treatment of inflammatory bowel disease. Biopharmaceutic and clinical pharmacokinetic characteristics.

Authors:  U Klotz; K E Maier; C Fischer; K H Bauer
Journal:  Arzneimittelforschung       Date:  1985

10.  An oral preparation to release drugs in the human colon.

Authors:  M J Dew; P J Hughes; M G Lee; B K Evans; J Rhodes
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

View more
  22 in total

Review 1.  Small bowel review: normal physiology part 2.

Authors:  A B Thomson; M Keelan; A Thiesen; M T Clandinin; M Ropeleski; G E Wild
Journal:  Dig Dis Sci       Date:  2001-12       Impact factor: 3.199

2.  Characterization of the contents of ascending colon to which drugs are exposed after oral administration to healthy adults.

Authors:  Amalia Diakidou; Maria Vertzoni; Konstantinos Goumas; Erik Söderlind; Bertil Abrahamsson; Jennifer Dressman; Christos Reppas
Journal:  Pharm Res       Date:  2009-07-02       Impact factor: 4.200

3.  Dynamic dissolution testing to establish in vitro/in vivo correlations for montelukast sodium, a poorly soluble drug.

Authors:  Arthur Okumu; Marie DiMaso; Raimar Löbenberg
Journal:  Pharm Res       Date:  2008-06-17       Impact factor: 4.200

Review 4.  Intestinal Absorption of Bile Acids in Health and Disease.

Authors:  Alexander L Ticho; Pooja Malhotra; Pradeep K Dudeja; Ravinder K Gill; Waddah A Alrefai
Journal:  Compr Physiol       Date:  2019-12-18       Impact factor: 9.090

Review 5.  Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs.

Authors:  S G Nugent; D Kumar; D S Rampton; D F Evans
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

Review 6.  A Quantitative Review and Meta-Models of the Variability and Factors Affecting Oral Drug Absorption-Part I: Gastrointestinal pH.

Authors:  Ahmad Y Abuhelwa; David J R Foster; Richard N Upton
Journal:  AAPS J       Date:  2016-08-05       Impact factor: 4.009

7.  Gastrointestinal pH profile in subjects with irritable bowel syndrome.

Authors:  David Lalezari
Journal:  Ann Gastroenterol       Date:  2012

Review 8.  The ileal brake: a fifteen-year progress report.

Authors:  G W Van Citters; H C Lin
Journal:  Curr Gastroenterol Rep       Date:  1999-10

9.  Wireless pH-motility capsule for colonic transit: prospective comparison with radiopaque markers in chronic constipation.

Authors:  M Camilleri; N K Thorne; Y Ringel; W L Hasler; B Kuo; T Esfandyari; A Gupta; S M Scott; R W McCallum; H P Parkman; E Soffer; G E Wilding; J R Semler; S S C Rao
Journal:  Neurogastroenterol Motil       Date:  2010-05-11       Impact factor: 3.598

10.  The assessment of regional gut transit times in healthy controls and patients with gastroparesis using wireless motility technology.

Authors:  I Sarosiek; K H Selover; L A Katz; J R Semler; G E Wilding; J M Lackner; M D Sitrin; B Kuo; W D Chey; W L Hasler; K L Koch; H P Parkman; J Sarosiek; R W McCallum
Journal:  Aliment Pharmacol Ther       Date:  2009-10-08       Impact factor: 8.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.